Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Early Prostate Cancer Recurrence With PSMA PET Positive Unilateral Pelvic Lesion(s): is One-sided Salvage Extended Lymph Node Dissection Enough

NCT04271579 is registered in ClinicalTrials.gov with Martini-Klinik am UKE GmbH as lead sponsor.

NCT NCT04271579
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04271579 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Early Prostate Cancer Recurrence With PSMA PET Positive Unilateral Pelvic Lesion(s): is One-sided Salvage Extended Lymph Node Dissection Enough
Lead sponsor
Martini-Klinik am UKE GmbH
Phase
Not applicable
Overall status
Recruiting
Start date
October 15, 2019
Completion date
December 31, 2028
Enrollment
397 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer